Treatment > Carmustine


Journal of Neuro-Oncology, 68 (3): 233-241, July 2004. (Laboratory Investigation)


Abstract

BCNU Down-Regulates Anti-Apoptotic Proteins Bcl-xL and Bcl-2 in Association with Cell Death in Oligodendroglioma-Derived Cells

Richard A. Lytle, Zhihong Jiang, Xiao Zheng, Keith M. Rich

Department of Neurosurgery, Washington University School of Medicine, St. Louis, MO, USA

Oligodendroglial differentiation in gliomas is associated with enhanced sensitivity to chemotherapy. 
Anti-apoptotic proteins, Bcl-xL and Bcl-2, are over-expressed in early passage cell lines derived from glioblastomas. 
Down-regulation of Bcl-xL and Bcl-2 with DNA antisense oligonucleotides promotes cell death in glioblastoma cells. 
Changes of expression of Bcl-xL and Bcl-2 after chemotherapy treatment have not been studied in glioma subtypes. 
The current experiments correlate decreased expression of both Bcl-xL and Bcl-2 after BCNU chemotherapy and cell death in two oligodendroglioma-derived cell lines. 
Expression of Bcl-2 family member proteins Bcl-xL, Bcl-2, and Bax were assessed in glioma cells both before and after chemotherapy treatment. 
Cell survival was assessed with a crystal violet bioassay. 
Levels of expression of Bcl-2 and Bcl-xL were elevated in two early passage oligodendroglioma-derived cell lines compared with a non-neoplastic glial cell line. 
BCNU chemotherapy markedly down-regulated expression of Bcl-xL and Bcl-2 proteins in both oligodendroglioma-derived cell lines. 
Changes in expression of Bcl-xL and Bcl-2 were associated with the increased sensitivity to chemotherapy. 
There were no changes noted in expression of Bax after BCNU treatment. 
Modulation of expression of the anti-apoptotic proteins, Bcl-xL and Bcl-2, in the two oligodendroglioma-derived cell lines was associated with increased sensitivity to BCNU chemotherapy. 
Down-regulation of Bcl-xL and Bcl-2 resulted in reversal of the ratio of Bax/Bcl-xL and Bax/Bcl-2 and enhanced cell death after treatment with BCNU. 
Mechanisms that control expression of the anti-apoptotic proteins Bcl-xL and/or Bcl-2 may be effective targets in treatment strategies in patients with malignant gliomas.

Keywords: apoptosis, brain tumors, cell death, chemotheropy, deamidation, gliomas

Copyright © 2004 Kluwer Academic Publishers. All rights reserved

Source: http://ipsapp009.kluweronline.com/IPS/content/ext/x/J/5042/I/119/A/7/abstract.htm


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP